Drug Trial Radar · NCT02734732
Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole
Last checked: Nov 19, 2026Latest source record: May 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,800
Planned (sponsor's estimate)
Start
Apr 2015
Primary completion
Apr 2020
Study completion May 2020
Sponsor
- Lead sponsor
- Umeå UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 12, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Male only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will examine if a single dose of Ciprofloxacin and Trimethoprim/Sulfamethoxazole are equivalent for prophylaxis immediately prior to prostate biopsy, when a patient has a suspected prostate cancer.
Conditions
- Prostate Infection
Interventions
Trimethoprim/SulfamethoxazoleDrug
CiprofloxacinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Admitted to hospital due to infectionTime frame: 14 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Ängelholm hospital
Ängelholm, Sweden · Not yet recruiting
Helsingborgs Hospital
Helsingborg, Sweden · Not yet recruiting
Umea University Hospital
Umeå, Sweden · Recruiting
Östersunds hospital
Östersund, Jämtland County, Sweden · Not yet recruiting
Sundsvalls hospital
Sundsvall, Västernorrland County, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.